Eric d'Esparbes
2020 - BIORA THERAPEUTICS
In 2020, Eric d'Esparbes earned a total compensation of $2.3M as Executive Vice President, Chief Financial Officer and Principal Financial Officer at BIORA THERAPEUTICS.
Compensation breakdown
| Non-Equity Incentive Plan | $135,000 |
|---|---|
| Option Awards | $964,988 |
| Salary | $450,000 |
| Stock Awards | $769,204 |
| Other | $17,670 |
| Total | $2,336,862 |
d'Esparbes received $965K in option awards, accounting for 41% of the total pay in 2020.
d'Esparbes also received $135K in non-equity incentive plan, $450K in salary, $769.2K in stock awards and $17.7K in other compensation.
Rankings
In 2020, Eric d'Esparbes' compensation ranked 4,845th out of 13,090 executives tracked by ExecPay. In other words, d'Esparbes earned more than 63.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,845 out of 13,090 | 63rd |
Division Manufacturing | 1,965 out of 5,620 | 65th |
Major group Chemicals And Allied Products | 774 out of 2,253 | 66th |
Industry group Drugs | 667 out of 1,953 | 66th |
Industry Pharmaceutical Preparations | 505 out of 1,458 | 65th |
Source: SEC filing on April 15, 2021.
d'Esparbes' colleagues
We found two more compensation records of executives who worked with Eric d'Esparbes at BIORA THERAPEUTICS in 2020.
News
BIORA THERAPEUTICS CEO Adi Mohanty's 2023 pay slips 11% to $3.1M
April 24, 2024
BIORA THERAPEUTICS CEO Adi Mohanty's 2022 pay falls 65% to $3.5M
April 27, 2023
BIORA THERAPEUTICS CEO Adi Mohanty receives $10M in 2021
April 28, 2022
BIORA THERAPEUTICS CEO Harry Stylli's 2020 pay jumps 1,357% to $5.8M
April 15, 2021
Innoviva CEO Michael Aguiar's 2018 pay slips 11% to $3.7M
March 13, 2019